[go: up one dir, main page]

AU3892593A - Composition for therapeutic or diagnostic use, process for its preparation and its use - Google Patents

Composition for therapeutic or diagnostic use, process for its preparation and its use

Info

Publication number
AU3892593A
AU3892593A AU38925/93A AU3892593A AU3892593A AU 3892593 A AU3892593 A AU 3892593A AU 38925/93 A AU38925/93 A AU 38925/93A AU 3892593 A AU3892593 A AU 3892593A AU 3892593 A AU3892593 A AU 3892593A
Authority
AU
Australia
Prior art keywords
therapeutic
preparation
composition
diagnostic
diagnostic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38925/93A
Inventor
Paavo Kai Johannes Kinnunen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3892593A publication Critical patent/AU3892593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6917—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a lipoprotein vesicle, e.g. HDL or LDL proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU38925/93A 1992-04-08 1993-04-07 Composition for therapeutic or diagnostic use, process for its preparation and its use Abandoned AU3892593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US865256 1986-05-20
US86525692A 1992-04-08 1992-04-08

Publications (1)

Publication Number Publication Date
AU3892593A true AU3892593A (en) 1993-11-18

Family

ID=25345059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38925/93A Abandoned AU3892593A (en) 1992-04-08 1993-04-07 Composition for therapeutic or diagnostic use, process for its preparation and its use

Country Status (6)

Country Link
EP (1) EP0634926A1 (en)
JP (1) JPH07505408A (en)
KR (1) KR950700726A (en)
AU (1) AU3892593A (en)
CA (1) CA2117749A1 (en)
WO (1) WO1993020800A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504797A (en) * 1993-11-08 1997-05-13 ペプチド デリバリー システムズ プロプリエタリイ リミテッド Labeled diagnostic composition and method of use thereof
DE19500665A1 (en) * 1995-01-12 1996-07-18 Axel Prof Dr Haase Process for the spatially resolving imaging of an area of a biological object with the help of electromagnetic rays using contrast media
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
DE60239552D1 (en) 2001-10-24 2011-05-05 Univ California MEASUREMENT OF PROTEIN SYNTHESIS IN HUMANS AND IN EXPERIMENTAL SYSTEMS BY USING ISOTOPICALLY MARKED WATER
EP1483399B1 (en) 2002-02-12 2008-10-29 The Regents of the University of California Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
CA2494715C (en) 2002-07-30 2014-07-08 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates using mass spectrometry
EP1546373B1 (en) * 2002-09-13 2008-11-26 The Regents of the University of California Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
EP1558293A4 (en) 2002-11-04 2006-10-25 Univ California TEST OF GLUCOSE DEUTERA TOLERANCE OR FAT FOR THE HIGH CAPACITY MEASUREMENT OF METABOLISM OF SUGARS OR FATTY ACIDS IN THE BODY
US7262020B2 (en) 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
US20050202406A1 (en) 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
EP2753707A4 (en) 2011-09-08 2015-03-04 Univ California MEASUREMENT OF METABOLIC FLOW, IMAGING AND MICROSCOPY
JP6294233B2 (en) 2011-12-07 2018-03-14 グラクソスミスクライン エルエルシー Quantification method for whole body skeletal muscle mass
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
KR102387248B1 (en) 2021-07-06 2022-04-15 (주)효림세울 Equipment for manufacturing sirofil Composite Yarn and sirofil Composite Yarn and method for manufacturing sirofil Composite Yarn
KR102713065B1 (en) 2022-04-11 2024-10-04 (주)효림세울 Equipment for manufacturing MOLTO JASPE yarn and method for manufacturing MOLTO JASPE yarn using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE456136B (en) * 1985-06-17 1988-09-12 Oncholab Ab PROCEDURE FOR THE PREPARATION OF A LIPOPHILIC BIOLOGY ACTIVE SUBSTANCE BASED BEARING BASIS OF RECONSTITUTED LDL (Layer Density Lipoprotein)

Also Published As

Publication number Publication date
KR950700726A (en) 1995-02-20
EP0634926A1 (en) 1995-01-25
JPH07505408A (en) 1995-06-15
WO1993020800A1 (en) 1993-10-28
CA2117749A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU6373094A (en) Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use
AU4000293A (en) Ophthalmologic cannula
SI0771788T1 (en) Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them
AU3072989A (en) Skin treatment composition
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
AU2364597A (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU4520893A (en) Sterilization process and composition
AU5229496A (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU6209790A (en) Pyridinyl-quinolone compounds, their preparation and use
AU4556096A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU2068295A (en) Skin treatment composition
AU3455393A (en) Preparation for skin use
AU4926190A (en) 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use
AU5668286A (en) Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use
AU3155497A (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU2353092A (en) Substituted aminopropanes, processes for their preparation, and their use
AU2752888A (en) Use of known compounds, novel compounds and the use and processes for preparation thereof
AU2371397A (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
AU3900895A (en) Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU5220893A (en) Substituted N-hydroxycinnamamides, processes for their preparation, compositions containing them, and their use
HUP9901126A3 (en) Pharmaceutical composition for external use containing nimesulide and process for the preparation thereof
AU6834790A (en) Thiazolyl-5-carbonamide derivatives, the preparation thereof composition containing them and their use against microorganisms
AU1265997A (en) Substituted thiophenylalkenylcarboxylic acid guanidides, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them